• 1. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 2. An all-solid-state asymmetric device based on a polyaniline hydrogel for a high energy flexible supercapacitor?
  Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244
• 3. An investigation into the origin of variations in photovoltaic performance using D–D–π–A and D–A–π–A triphenylimidazole dyes with a copper electrolyte?
  Govind Reddy Mol. Syst. Des. Eng., 2021,6, 779-789
• 4. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
• 5. An approach to asymmetric synthesis of β-aryl alanines by Pd(0)-catalyzed cross-coupling and cyanate-to-isocyanate rearrangement?
  Piotr Szcze?niak,Sebastian Stecko RSC Adv., 2015,5, 30882-30888

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ketones
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbonyl compounds Ketones

Research Brief on 2-(Pyridin-3-yl)-1-(p-tolyl)ethanone (CAS: 224040-91-9) in Chemical Biology and Pharmaceutical Applications

2-(Pyridin-3-yl)-1-(p-tolyl)ethanone (CAS: 224040-91-9) is a compound of significant interest in the field of chemical biology and pharmaceutical research. This molecule, characterized by its pyridine and p-tolyl functional groups, has been the subject of recent studies due to its potential applications in drug discovery and development. The compound's unique structural features make it a promising candidate for modulating biological targets, particularly in the context of kinase inhibition and anti-inflammatory therapies.

Recent literature highlights the synthesis and characterization of 2-(Pyridin-3-yl)-1-(p-tolyl)ethanone, with a focus on its physicochemical properties and reactivity. Advanced spectroscopic techniques, including NMR and mass spectrometry, have been employed to confirm its structure and purity. Computational studies, such as molecular docking and density functional theory (DFT) calculations, have provided insights into its binding affinities and electronic properties, which are critical for understanding its interactions with biological targets.

In pharmacological research, 2-(Pyridin-3-yl)-1-(p-tolyl)ethanone has shown promising activity in preliminary in vitro assays. Studies indicate its potential as an inhibitor of specific kinases involved in inflammatory pathways, suggesting its utility in developing novel anti-inflammatory agents. Additionally, its metabolic stability and pharmacokinetic profile have been evaluated, with results indicating favorable properties for further drug development. These findings underscore the compound's relevance in addressing unmet medical needs in inflammation-related disorders.

The compound's mechanism of action has been explored in cellular models, where it demonstrated the ability to modulate key signaling pathways. For instance, it has been shown to inhibit the production of pro-inflammatory cytokines, such as TNF-α and IL-6, in macrophage cell lines. These effects are attributed to its interaction with specific kinase domains, which play a pivotal role in the regulation of immune responses. Such mechanistic insights are invaluable for optimizing the compound's structure to enhance its efficacy and selectivity.

Despite these promising findings, challenges remain in the development of 2-(Pyridin-3-yl)-1-(p-tolyl)ethanone as a therapeutic agent. Issues such as solubility, bioavailability, and potential off-target effects need to be addressed through further structural modifications and formulation studies. Ongoing research aims to explore derivatives of this compound to improve its pharmacological properties while minimizing adverse effects. Collaborative efforts between academic and industrial researchers are expected to accelerate the translation of these findings into clinical applications.

In conclusion, 2-(Pyridin-3-yl)-1-(p-tolyl)ethanone (CAS: 224040-91-9) represents a promising scaffold in chemical biology and pharmaceutical research. Its demonstrated biological activity, coupled with its favorable physicochemical properties, positions it as a valuable candidate for further investigation. Future studies should focus on optimizing its structure, elucidating its detailed mechanism of action, and evaluating its efficacy in preclinical models. The continued exploration of this compound holds significant potential for advancing therapeutic strategies in inflammation and related disorders.

• 40061-21-0(2-(4-Methylphenyl)-1-(3-pyridinyl)-1-ethanone)
• 62144-16-5(1-Propanone, 1-phenyl-2-(3-pyridinyl)-)
• 14627-92-0(2-Phenyl-1-(3-pyridinyl)-ethanone)
• 87372-75-6(1-Propanone,2-methyl-1-phenyl-2-(3-pyridinyl)-)
• 1570-48-5(3-Propionylpyridine)
• 40061-31-2(1,2-Ethanedione,1-(4-methylphenyl)-2-(3-pyridinyl)-)
• 1081-48-7(Ethanone,1-phenyl-2-(3-pyridinyl)-)
• 62144-15-4(1-Propanone, 2-phenyl-1-(3-pyridinyl)-)
• 62144-14-3(Ethanone, 1,2-diphenyl-2-(3-pyridinyl)-)
• 6339-93-1(Ethanone,1,2-di-3-pyridinyl-)